Antidepressant Use and Circulating Lipoprotein(a) Levels: A UK Biobank Analysis Including LPA Variant Carriers
Journal of Lipid Research · 2026-10 · 101174
DOI: 10.1016/j.jlr.2026.101174 ↗Kurz gefasst
Fachartikel in der Zeitschrift Journal of Lipid Research, 2026-10. Verfasst von Iosif Taleb und 4 weiteren Autor:innen. Beteiligte Einrichtung: Division of Cardiovascular Medicine, University of California San Diego, La Jolla, USA. Die Arbeit nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ionis Pharmaceuticals Inc, National Heart Lung and Blood Institute.
Abstract (Originalsprache)
Experimental studies suggest that serotonergic antidepressants may enhance hepatic uptake of lipoprotein(a) [Lp(a)] through serotonin-dependent endocytic pathways, but whether antidepressant use is associated with circulating Lp(a) concentrations in humans remains unknown. We evaluated the cross-sectional association between antidepressant use and circulating Lp(a) and apolipoprotein(a) [apo(a)] levels in a large population-based cohort. We analyzed UK Biobank data including serum Lp(a) measured by immunoturbidimetry (n=365,459) and plasma apo(a) quantified by Olink proteomics (n=38,937). Antidepressant use and Lp(a)/apo(a) measurements were ascertained at the same baseline assessment. Multivariable linear regression models assessed associations of three selective serotonin reuptake inhibitors (SSRIs; citalopram, sertraline, paroxetine), two tricyclic antidepressants (TCAs; imipramine, amitriptyline), and combined exposure groups with rank-based inverse normal transformed Lp(a) and apo(a) levels. Analyses were performed in the full cohort, restricted to European ancestry, and among carriers of the LPA variants rs3798220 and rs10455872. Across 112 prespecified models, no antidepressant was significantly associated with Lp(a) or apo(a) levels after Bonferroni correction (P < 4.5 × 10-4). Regression coefficients were uniformly small with no consistent pattern in magnitude or direction. Results were consistent across Lp(a) and apo(a) assays and ancestry strata; carrier-restricted analyses were generally concordant but less precise because of smaller sample sizes. In this large cross-sectional population-based study, SSRI and TCA use were not associated with circulating Lp(a) or apo(a) levels. Small, dose-dependent, duration-dependent, or within-person treatment effects cannot be excluded. Further mechanistic and longitudinal studies are warranted to clarify serotonergic influences on Lp(a) metabolism.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Division of Cardiovascular Medicine, University of California San Diego, La Jolla, USA.
- Ionis Pharmaceuticals, Carlsbad, CA, USA.
- University of Utah Molecular Medicine Program, University of Utah, Salt Lake City, UT, USA; Department of Pathology, Division of Microbiology & Immunology, University of Utah School of Medicine, Salt Lake City, UT, USA;…
- Division of Cardiovascular Medicine, University of California San Diego, La Jolla, USA; Ionis Pharmaceuticals, Carlsbad, CA, USA. Electronic address: stsimikas@health.ucsd.edu.
Förderung
- Ionis Pharmaceuticals Inc
- National Heart Lung and Blood Institute
Zitieren
APA
Taleb, I., Astore, C., Praveen, K., Gordts, P. L. S. M., & Tsimikas, S. (2026). Antidepressant Use and Circulating Lipoprotein(a) Levels: A UK Biobank Analysis Including LPA Variant Carriers. Journal of Lipid Research, 101174. https://doi.org/10.1016/j.jlr.2026.101174
Vancouver
Taleb I, Astore C, Praveen K, Gordts PLSM, Tsimikas S. Antidepressant Use and Circulating Lipoprotein(a) Levels: A UK Biobank Analysis Including LPA Variant Carriers. Journal of Lipid Research. 2026:101174. doi:10.1016/j.jlr.2026.101174
BibTeX
@article{Taleb2026,
author = {Taleb, Iosif and Astore, Courtney and Praveen, Kavita and Gordts, Philip L S M and Tsimikas, Sotirios},
title = {Antidepressant Use and Circulating Lipoprotein(a) Levels: A UK Biobank Analysis Including LPA Variant Carriers},
journal = {Journal of Lipid Research},
year = {2026},
pages = {101174},
doi = {10.1016/j.jlr.2026.101174}
}
EUVIMED